Published in Br J Anaesth on April 01, 1985
Anesthetic implication of tricuspid valve replacement in a patient with acute intermittent porphyria. Ann Card Anaesth (2016) 0.75
Anaesthesia for the porphyric patient. Anaesthesia (1993) 3.12
Blood-lead and hypertension. Lancet (1976) 2.82
The screening of propofol in MHS swine. Anesth Analg (1989) 2.75
Environmental lead pollution in an urban soft-water area. Br Med J (1972) 2.28
Control of the malignant hyperpyrexic syndrome in MHS swine by dantrolene sodium. Br J Anaesth (1975) 1.95
Hereditary coproporphyria. Demonstration of the abnormalities in haem biosynthesis in peripheral blood. Q J Med (1977) 1.91
Anaesthetic-induced malignant hyperpyrexia and a method for its prediction. Br J Anaesth (1969) 1.83
The acute porphyrias. Lancet (1997) 1.80
Tin protoporphyrin prolongs the biochemical remission produced by heme arginate in acute hepatic porphyria. Gastroenterology (1993) 1.76
Controlled trial of haem arginate in acute hepatic porphyria. Lancet (1989) 1.75
Low level exposure to lead. BMJ (1990) 1.67
Life satisfaction and quality in Korean War veterans five decades after the war. J Epidemiol Community Health (2009) 1.48
Depression of delta-aminolaevulic acid dehydrase activity by ethanol in man and rat. Clin Sci (1971) 1.45
Re-assessment of risk factors for sporadic Salmonella serotype Enteritidis infections: a case-control study in five FoodNet Sites, 2002-2003. Epidemiol Infect (2006) 1.43
Control of the malignant hyperpyrexic syndrome in MHS swine by dantrolene sodium. 1975. Br J Anaesth (1998) 1.39
Role of chronic low-level lead exposure in the aetiology of mental retardation. Lancet (1975) 1.39
Acute intermittent porphyria: response of tachycardia and hypertension to propranolol. Br Med J (1973) 1.35
Treatment with haematin in acute hepatic porphyria. Q J Med (1981) 1.29
Renal insufficiency associated with excessive lead exposure. Br Med J (1977) 1.29
Changes underlying halothane-induced malignant hyperpyrexia in Landrace pigs. Nature (1970) 1.26
Chronic peroxisome proliferation and hepatomegaly associated with the hepatocellular tumorigenesis of di(2-ethylhexyl)phthalate and the effects of recovery. Toxicol Sci (1999) 1.23
The neurotoxicology of lead. Neurotoxicology (1986) 1.22
Death attributable to anaesthesia. A 10-year survey (1967--1976). Br J Anaesth (1978) 1.21
Computer-assisted interactive three-dimensional planning for neurosurgical procedures. Neurosurgery (1996) 1.19
Induction of delta-aminolaevulinic acid synthase in leucocytes of patients on phenytoin therapy--comparison with changes in rat hepatic tissue. Br J Clin Pharmacol (1980) 1.19
Tetraethyl-lead poisoning. Lancet (1972) 1.18
Hyperpyrexia during anaesthesia. Br Med J (1968) 1.17
Screening for latent acute intermittent porphyria: the value of measuring both leucocyte delta-aminolaevulinic acid synthase and erythrocyte uroporphyrinogen-1-synthase activities. J Med Genet (1982) 1.15
[Contribution of lead in drinking water to blood-lead]. Lancet (1977) 1.15
MOPP chemotherapy for advanced Hodgkin's disease. Prognostic factors in 81 patients. Cancer (1973) 1.14
Heme biosynthesis in Friend erythroleukemia cells: control by ferrochelatase. Proc Natl Acad Sci U S A (1979) 1.14
Onset and evolution of stunting in infants and children. Examples from the Human Nutrition Collaborative Research Support Program. Kenya and Egypt studies. Eur J Clin Nutr (1994) 1.14
Food iron and lead absorption in humans. Am J Clin Nutr (1986) 1.13
Effect of certain anaesthetic agents on the activity of rat hepatic delta-aminolaevulinate synthase. Br J Anaesth (1978) 1.13
Relation of maternal zinc nutriture to pregnancy outcome and infant development in an Egyptian village. Am J Clin Nutr (1994) 1.13
Various Bacillus Typhosus Antigens Used for the Macroscopic Widal. Am J Public Health Nations Health (1935) 1.12
Methylenetetrahydrofolate dehydrogenase from Clostridium formicoaceticum and methylenetetrahydrofolate dehydrogenase, methenyltetrahydrofolate cyclohydrolase (combined) from Clostridium thermoaceticum. Methods Enzymol (1980) 1.11
Blood-lead and cadmium in human hypertension. J Environ Pathol Toxicol (1980) 1.09
Vitamin B-6 status of Egyptian mothers: relation to infant behavior and maternal-infant interactions. Am J Clin Nutr (1990) 1.09
Deaths associated with anaesthesia--a lesson for South Africa. S Afr Med J (1996) 1.09
Differential response to targeted recruitment strategies to fitness promotion research by African-American women of varying body mass index. Ethn Dis (2001) 1.08
Fusion of liposomes containing conductance probes with black lipid films. Biochim Biophys Acta (1976) 1.08
Safe levels of cadmium intake to prevent renal toxicity in human subjects. Br J Nutr (2000) 1.08
Androgenic control of the harderian gland in the male golden hamster. J Endocrinol (1977) 1.08
Autonomic neuropathy in acute intermittent porphyria. J Neurol Neurosurg Psychiatry (1985) 1.07
Is lead in tap water still a public health problem? An observational study in Glasgow. BMJ (1996) 1.07
Randomized comparison between low-pressure laparoscopic cholecystectomy and gasless laparoscopic cholecystectomy. Surg Endosc (1999) 1.07
Oral absorption of lead and iron. Lancet (1980) 1.06
Purification and characterization of nicotinamide adenine dinucleotide-dependent methylenetetrahydrofolate dehydrogenase from Clostridium formicoaceticum. J Biol Chem (1974) 1.05
The effect of calcium on lead absorption in rats. Biochem J (1977) 1.05
Maternal lead levels after alterations to water supply. Lancet (1981) 1.03
Successful abatement of lead exposure from water supplies in the West of Scotland. Environ Res (1985) 1.03
Effects of aluminium, lead and zinc on delta-aminolaevulinic acid dehydratase. Enzyme (1977) 1.03
Enzyme abnormalities in the porphyrias. Lancet (1977) 1.02
Quantitative analysis of the time-dependent development of glucose-6-phosphatase-deficient foci in the livers of mice treated neonatally with diethylnitrosamine. Cancer Res (1981) 1.02
Lead in water, infant diet and blood: the Glasgow Duplicate Diet Study. Sci Total Environ (1985) 1.01
Mast cells in the hamster Harderian gland: sex differences, hormonal control and relationship to porphyrin. J Anat (1982) 1.01
Leptospiral antibodies in flying foxes in Australia. J Wildl Dis (2002) 1.01
Effect of carbamazepine on haem biosynthesis in man. Eur J Clin Invest (1984) 1.01
A retrospective analysis of blood-lead in mentally retarded children. Lancet (1977) 1.00
Blood-cadmium in hypertensives and normotensives. Lancet (1976) 1.00
Is porphobilinogen deaminase activity a secondary control mechanism in haem biosynthesis in humans? [proceedings]. Biochem Soc Trans (1977) 0.99
Effect of rifampicin on haem and bilirubin metabolism in man. Br J Clin Pharmacol (1987) 0.98
Excessive urinary excretion of certain porphyrinogenic steroids in human acute intermittent porphyria. Lancet (1969) 0.98
Environmental chemical exposures and disturbances of heme synthesis. Environ Health Perspect (1997) 0.98
The Harderian gland, its secretory duct and porphyrin content in the mongolian gerbil (Meriones unguiculatus). J Anat (1983) 0.97
Assessing the accuracy of a food frequency questionnaire for estimating usual intake of phytoestrogens. Nutr Cancer (2000) 0.97
A possible protective role for sulphydryl compounds in acute alcoholic liver injury. Biochem Pharmacol (1977) 0.96
Development and evaluation of a colour-coded scale for birthweight surveillance in rural Egypt. Int J Epidemiol (1989) 0.96
International review of drugs in acute porphyria--1980. Int J Biochem (1980) 0.96
Seasonal variation in delta-aminolaevulinate synthase and porphyrin content in the Harderian gland of the female golden hamster (Mesocricetus auratus). Int J Biochem (1980) 0.96
Purification of and kinetic studies on a cloned protoporphyrinogen oxidase from the aerobic bacterium Bacillus subtilis. Arch Biochem Biophys (1998) 0.95
Sex differences in haem biosynthesis and porphyrin content in the Harderian gland of the golden hamster. Int J Biochem (1984) 0.95
Cylindrospermopsin, a cyanobacterial alkaloid: evaluation of its toxicologic activity. Ther Drug Monit (2000) 0.95
Hepatic delta-aminolaevulinic acid synthetase in an attack of hereditary coproporphyria and during remission. Lancet (1971) 0.95
Acute lead poisoning: an unusual cause of hepatitis. Scott Med J (1979) 0.94
Kinetics of lead following intravenous administration in man. Toxicol Lett (1984) 0.94
Erythrocyte osmotic fragility in hyperthermia-susceptible swine. Br J Anaesth (1973) 0.94
Progestin effects on growth in the human breast cancer cell line T-47D--possible therapeutic implications. Biochem Biophys Res Commun (1987) 0.94
Familial and congenital polycythemia in three unrelated families. Blood (1992) 0.94
The contribution of drinking water lead to maternal blood lead concentrations. Clin Chim Acta (1979) 0.94
Relationships between non-occupational cadmium exposure and expression of nine cytochrome P450 forms in human liver and kidney cortex samples. Biochem Pharmacol (2001) 0.94
Acute hepatic coma treated by cross-circulation with a baboon and by repeated exchange transfusions. Lancet (1968) 0.93
Acute ethanol ingestion and haem biosynthesis in healthy subjects. Eur J Clin Invest (1980) 0.92
Molecular characterization of erythropoietic protoporphyria in South Africa. Br J Dermatol (2008) 0.92
Alterations in haem biosynthesis during the human menstrual cycle: studies in normal subjects and patients with latent and active acute intermittent porphyria. Clin Sci (Lond) (1982) 0.92
A human in vivo model for the determination of lead bioavailability using stable isotope dilution. Environ Health Perspect (1996) 0.91
The biosynthesis of haem in congenital (erythropoietic) porphyria. Int J Biochem (1978) 0.91
Some studies of maternal and infant lead exposure in Glasgow. Scott Med J (1982) 0.91
Pregnancy and the acute porphyrias. Br J Obstet Gynaecol (1977) 0.90
Hypoxanthine-guanine phosphoribosyltransferase. Characterization of a mutant in a patient with gout. J Clin Invest (1975) 0.90
Nutrition screening in older persons. J Am Geriatr Soc (1995) 0.90
Hereditary coproporphyria and epilepsy. Arch Dis Child (1977) 0.90
17-Oxosteroid conjugates in plasma and urine of patients with acute intermittent porphyria. Clin Sci Mol Med (1974) 0.90
The effects of industrial lead poisoning on cytochrome P450 mediated phenazone (antipyrine) hydroxylation. Eur J Clin Pharmacol (1977) 0.90
A feasibility study of a new approach to clinical radiosensitisation: hypothermia and hyperbaric oxygen in combination with pharmacological vasodilatation. Br J Radiol (1986) 0.90
Diet during lactation associated with infant behavior and caregiver-infant interaction in a semirural Egyptian village. J Nutr (1993) 0.90
Pathogenesis and treatment of acute intermittent porphyria: discussion paper. J R Soc Med (1983) 0.90
Anaesthetic-induced malignant hyperpyrexia: a suggested method of treatment. Br Med J (1971) 0.90